Doebele R, et al. Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.01.
Betere diagnostiek neuro-endocriene tumoren in de long
sep 2022 | Longoncologie